Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tris Pharma
Biotech
Biopharma veteran takes her CEO Cue—Chutes & Ladders
Biopharma veteran takes her CEO Cue. Kyverna nabs commercial chief to prep for launch. Anavex promotes from within after ousting CEO.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
May 8, 2026 8:30am
Tris' next-gen pain drug completes trio of clinical wins
Mar 6, 2025 8:30am
Tris shows its opioid alternative is less likely to be abused
Jan 28, 2025 10:53am
Tris' opioid alternative reduces post-surgery pain in phase 3
Jan 22, 2025 8:30am
Cerevel swaps CEO—Chutes & Ladders
May 5, 2023 9:30am
Back-to-back FDA rejections leave Vernalis reeling
Aug 7, 2017 7:49am